Showing results (101-110 of 122) with videos related to
Sort By:
Pageof 13
Frontiers in Medicine|January 26, 2023
Clinical features and outcomes of patients with myositis associated-interstitial lung diseaseTheodoros Karampitsakos, Vasilios Tzilas, Ourania Papaioannou, et al.Journal of Clinical Immunology|May 20, 2023
Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 PneumoniaQuentin Philippot, Arnaud Fekkar, Adrian Gervais, et al.American Journal of Respiratory and Critical Care Medicine|May 22, 2020
Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1Etienne-Marie Jutant, Xavier Jaïs, Barbara Girerd, et al.BMC Pulmonary Medicine|July 7, 2026
Geographical, institutional and workplace variability in genetic evaluation, screening practices, multidisciplinary care, and lung transplantation management for familial interstitial lung diseaseEmil Vilstrup Moen, Thomas Prior, Michael Kreuter, et al.Plos One|December 16, 2020
Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort studyRaphael Borie, Laurent Savale, Antoine Dossier, et al.The European Respiratory Journal|August 7, 2025
Update of the International Multidisciplinary Classification of the Interstitial Pneumonias: An ERS/ATS StatementChristopher J Ryerson, Ayodeji Adegunsoye, Sara Piciucchi, et al.Mayo Clinic Proceedings|February 7, 2021
Arterial Thrombotic Events in Adult Inpatients With COVID-19Morgane Fournier, Dorothée Faille, Antoine Dossier, et al.RMD Open|June 5, 2025
Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodiesMarie Robert, Yann Nguyen, Yves Allenbach, et al.Blood|November 25, 2025
Somatic genetic rescue in ZCCHC8-associated telomere biology disordersSophie De Tocqueville, Flavia Donaires, Nicholas F DeCleene, et al.The European Respiratory Journal|May 25, 2023
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trialJulie Mankikian, Agnès Caille, Martine Reynaud-Gaubert, et al.Pageof 13